Safe Use of Immune Checkpoint Inhibitors in Patients With Autoimmune Disease in a Community Hospital Setting: A Report of Two Cases

By sjmartinez • May 10, 2025

Shah VD, Bansil S, Reed JP. Safe Use of Immune Checkpoint Inhibitors in Patients With Autoimmune Disease in a Community Hospital Setting: A Report of Two Cases. Cureus. 2025 Apr 8;17(4):e81877. doi: 10.7759/cureus.81877. PMID: 40342434; PMCID: PMC12060583.

Tags: autoimmune disease, clinical trial inclusion, Fellow, General Internal Medicine, Hematology/Oncology, immune checkpoint inhibitor, immune related adverse events, Olive View DoM, Publications, Resident, rheumatologic disease

Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead

Tang AB, Lewsey SC, Yancy CW, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Thomas K, Fonarow GC. Get[...]

Validating the Sino-Nasal Outcome Test (SNOT-22) in comparison to the Sino-Nasal 5 Questionnaire (SN-5) in a pediatric population

Cheng MY, Rodriguez DR, Rubio A, Jackson NJ, West AN. Validating the Sino-Nasal Outcome Test (SNOT-22) in comparison to the Sino-Nasal 5 Questionnaire (SN-5) in[...]

CTA in roadmapping post-CABG evaluation

Golub IS, Misic A, Krishnan S, Hubbard L, Chatterjee D, Lopez R, Benzing T, Kianoush S, Ichikawa K, Aldana-Bitar J, Budoff MJ. CTA in roadmapping[...]